The firm served as lead counsel for Biotec Pharmacon, ASA, a Norwegian pharmaceutical company, in patent infringement litigation initiated by patent owner Biothera, a Minnesota corporation, in the District of Minnesota in Minneapolis. The 14 patents involved in the litigation relate to, among other things, beta glucan compositions for immunotherapy. The District Court granted summary judgment of non-infringement as to 12 of the 14 patents, and the case subsequently settled.

Biopolymer Eng'g, Inc. v. Immunocorp, No. 05-00536 (D. Minn. filed Mar. 14, 2005).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Acquisition for a developer of commercial and residential properties
The firm served as lead counsel in the acquisition for a developer of commercial and residential properties. more
Multi-family dispositions for Gables Residential
Representation of Gables Residential in the disposition of multi-family properties throughout the country. Representation in this project includes: more
Headquarters lease negotiations for Nestlé Waters North America, Inc.
Represented Nestlé Waters North America, Inc. in the negotiation of lease for 165,000 square foot headquarter office facility in Stamford, more
Real estate advice for one of Scandinavia's leading architectural and health planning consultants
Represented one of  Scandinavia's leading architectural and health planning consultants in the drafting and negotiation of design agreements for more